Cargando…
Second-Generation Trabecular Micro-Bypass Stents as Standalone Treatment for Glaucoma: A 36-Month Prospective Study
INTRODUCTION: To evaluate long-term outcomes following stand-alone implantation of two second-generation trabecular micro-bypass stents (iStent inject(®), Glaukos Corp., San Clemente, CA, USA) in eyes with predominantly primary open-angle glaucoma (POAG) and considerable preoperative disease burden....
Autores principales: | Hengerer, Fritz H., Auffarth, Gerd U., Riffel, Christoffer, Conrad-Hengerer, Ina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824385/ https://www.ncbi.nlm.nih.gov/pubmed/31119690 http://dx.doi.org/10.1007/s12325-019-00984-9 |
Ejemplares similares
-
Prospective, Non-randomized, 36-Month Study of Second-Generation Trabecular Micro-Bypass Stents with Phacoemulsification in Eyes with Various Types of Glaucoma
por: Hengerer, Fritz H., et al.
Publicado: (2018) -
iStent inject Trabecular Micro-Bypass with or Without Cataract Surgery Yields Sustained 5-Year Glaucoma Control
por: Hengerer, Fritz H., et al.
Publicado: (2022) -
Comparison of Minimally Invasive XEN45 Gel Stent Implantation in Glaucoma Patients Without and With Prior Interventional Therapies
por: Hengerer, Fritz H., et al.
Publicado: (2019) -
Ab interno gel implant in patients with primary open angle glaucoma and pseudoexfoliation glaucoma
por: Hengerer, Fritz H., et al.
Publicado: (2018) -
Newly Diagnosed Primary Open-Angle Glaucoma Randomized to 2 Trabecular Bypass Stents or Prostaglandin: Outcomes Through 36 Months
por: Vold, Steven D., et al.
Publicado: (2016)